Patents Assigned to Oklajoma Medical Research Foundation
  • Method for treatment of insulin resistance in obesity and diabetes
    Patent number: 6689938
    Abstract: Disclosed is a method to identify compounds useful for reducing insulin resistance in a patient, and particularly a patient that has insulin resistance associated with obesity and/or type II diabetes. Also disclosed is a method of reducing insulin resistance in a patient by administering a compound identified using the method of the invention, and particularly, by administering an antagonist of melanocortin stimulating hormone (MSH) biological activity.
    Type: Grant
    Filed: September 13, 2001
    Date of Patent: February 10, 2004
    Assignee: Oklajoma Medical Research Foundation
    Inventors: Miles B. Brennan, Ute Hochgeschwender